Safety and Efficacy of Cannabis in Autism Spectrum Disorder.

Spread the love


. 2020 Dec 24;34:25.

doi: 10.15844/pedneurbriefs-34-25.


Item in Clipboard


Abhinaya Ganesh et al. Pediatr Neurol Briefs. .


Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months.

Keywords: ASD; Autism; CBD; Cannabidiol; Cannabis; Neurodevelopment; Neurology; Pediatrics; THC.

Conflict of interest statement

The authors have declared that no competing interests exist.

Comment on

Similar articles


    1. Bar-Lev Schleider L, Mechoulam R, Saban N, Meiri G, Novack V. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy. Sci Rep. 2019 Jan;9(1):200. doi: 10.1038/s41598-018-37570-y. – DOI PMC PubMed
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Washington (DC): Publisher; 2013.
    1. Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019 Oct;19(1):328. doi: 10.1186/s12888-019-2259-4. – DOI PMC PubMed
    1. Wei D, Dinh D, Lee D, Li D, Anguren A, Moreno-Sanz G, et al. Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment. Cannabis Cannabinoid Res. 2016 Feb;1(1):81–9. doi: 10.1089/can.2015.0008. – DOI PMC PubMed
    1. Barchel D, Stolar O, De-Haan T, Ziv-Baran T, Saban N, Fuchs DO, et al. Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities. Front Pharmacol. 2019 Jan;9:1521. doi: 10.3389/fphar.2018.01521. – DOI PMC PubMed

Publication types



error: Content is protected !!
%d blogueurs aiment cette page :